# Negative Pressure Wound Therapy for the Prevention of Surgical Site Infection Following Lower Limb Revascularization

> **NCT02084017** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Western University, Canada** · enrollment: 80 (estimated)

## Conditions studied

- Surgical Wound Infection
- Peripheral Vascular Diseases

## Interventions

- **DEVICE:** Prevena (Negative Pressure Wound Therapy Device)
- **DEVICE:** Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing

## Key facts

- **NCT ID:** NCT02084017
- **Lead sponsor:** Western University, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2015-10
- **Final completion:** 2016-04
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084017, "Negative Pressure Wound Therapy for the Prevention of Surgical Site Infection Following Lower Limb Revascularization". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02084017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*